DoW Tuberous Sclerosis Complex, Exploration-Hypothesis Development Award
Agency: Defense Health Agency Contracting Activity - DHACA
- 12.420 -- Military Medical Research and Development
Archived opportunityLast Updated: May 13, 2026
Important dates
- Archived: September 5, 2026
- Closed: August 6, 2026
Award details
- Expected project funding: $2,100,000
- Expected awards: 6
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:HT942526TSCRPEHDA
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Science technology and other research and development
- Category Explanation:Not specified
History
- Posted date: May 5, 2026
- Archive date: September 5, 2026
- Version: 1
Summary
Jump to documentsSummary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts in the tuberous sclerosis complex (TSC) research field.
Distinctive Features: Preliminary Data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.
Eligibility
Miscellaneous
- Unrestricted
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| HT942526TSCRPEHDA_GG.pdf | FY26 TSCRP EHDA Program Announcement | May 8, 2026 10:55 AM UTC |
Agency contact information
Email: help@eBRAP.org
CDMRP Help Desk
Link to additional information
No additional information is available
